Spray-Dried Biologics Market Size Projected To Increase From $2.07 Billion To $3.2 Billion During The Forecast Period
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Spray-Dried Biologics Market Expansion From $2.07 Billion In 2026 To $3.2 Billion In 2030
The market for spray-dried biologics has experienced swift expansion in recent times. Valued at $1.86 billion in 2025, it is projected to reach $2.08 billion by 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. This historical growth has been driven by progress in biologics formulation science, a rise in biologic drug approvals, a demand for enhanced drug stability, an increase in vaccine production capacity, and the uptake of cutting-edge pharmaceutical processing methods.
The spray-dried biologics market is anticipated to experience significant expansion over the coming years. By 2030, its value is projected to reach $3.2 billion, driven by a compound annual growth rate of 11.4%. This forecasted growth is fueled by several factors, including a heightened demand for non-injectable biologics, increased investments in dry powder delivery technologies, the worldwide scaling of vaccine manufacturing, a greater emphasis on minimizing cold-chain requirements, and enhancements in spray-drying equipment design. Key trends shaping this period involve the broader application of spray-drying to improve biologic stability, a rising preference for inhalable and oral biologic formulations, the advancement of continuous spray-drying methods, a growing utilization of dry powder biologics in vaccines, and an intensified focus on extending product shelf life.
Download A Free Sample Report For Comprehensive Market Insights:
Spray-Dried Biologics Market Industry Drivers: What Is Driving Revenue Growth?
The spray-dried biologics market is anticipated to benefit from a growing appetite for biopharmaceuticals moving forward. Biopharmaceuticals represent therapeutic goods sourced from living organisms, such as cells, proteins, and other biological molecules. This sector’s expansion is fueled by a worldwide increase in chronic and complicated diseases, resulting in an urgent requirement for treatments that provide better precision, enhanced effectiveness, and reduced systemic side effects. Consequently, the spray-dried biologics field is seeing heightened interest as the swift progress of biopharmaceuticals encourages firms to embrace scalable formulation methods that boost stability, prolong shelf life, and improve delivery performance. A case in point is February 2025, when the World Health Organization (WHO), a Switzerland-based global public health body, reported that the 2023 WHO essential medicines list (EML) contained 81 biologic therapies, representing over 15% of all essential medicines. Thus, the spike in biopharmaceutical demand is pushing the spray-dried biologics market ahead.
Spray-Dried Biologics Market Segment Breakdown: Which Categories Generate The Most Revenue?
The spray-dried biologics market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types
2) By Route Of Administration: Oral, Inhalation Or Pulmonary, Injectable, Topical
3) By End-User: Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Monoclonal Antibodies: Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments
2) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines
3) By Enzymes: Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes
4) By Hormones: Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones
5) By Other Product Types: Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins
Spray-Dried Biologics Market Growth Trends: What Is Influencing The Future Outlook?
Key industry players in the spray-dried biologics space are increasingly adopting innovations like drum dosing technology to improve dose precision, powder handling, and high-volume capsule filling reliability. This advanced powder-filling technique relies on a rotating drum fitted with precisely designed dosing cavities and vacuum-assisted transfer to accurately measure and dispense dry powders into capsules, offering benefits such as consistent filling at low doses, better flow control for spray-dried powders, and scalable throughput. A notable example occurred in February 2024, when Catalent Inc., a US-based contract development and manufacturing organization (CDMO), enhanced its inhalation manufacturing site in the United States by incorporating potent capsule-filling capabilities that use drum-based dosing systems alongside in-line advanced mass verification. This upgraded configuration supports precise filling of engineered and spray-dried powders, with in-process dose validation and controlled low-humidity conditions. Such improvements boost manufacturing efficiency, ensure product uniformity, and prepare the facility for commercial-scale output of spray-dried biologic dry-powder inhalation treatments.
Spray-Dried Biologics Market Key Players And Strategic Industry Positioning
Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BÜCHI Labortechnik AG.
Access The Complete Spray-Dried Biologics Market Report:
Spray-Dried Biologics Market Regional Analysis And Leading Geography
North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
